Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes

Alan Rodney, Pauline Dieringer, Paul Mathew, Eric Jonasch, Nizar Tannir, Lance C. Pagliaro

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes'. Together they form a unique fingerprint.

Medicine & Life Sciences